Status
Conditions
Treatments
About
This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients receiving oral anti-cancer therapy other than abiraterone and enzalutamide.
Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group)
Primary purpose
Allocation
Interventional model
Masking
80 participants in 2 patient groups
Loading...
Central trial contact
Stacey Hubay, MD, FRCPC; Carla Girolametto, MA, MHSC
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal